As we already reported a few days ago, over 60% of the new COVID cases involve people who have already been vaccinated.
And now, an alarming new report in Microbiology and Infectious Disease reveals the mRNA vaccines could easily trigger Alzheimer’s disease, ALS, and other neurological and cognitive degenerative diseases.
From the report of J. Bart Classen, MD:
Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARS- CoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing.
Dr. Classen and his colleagues discovered that the vaccine increases the likelihood of these hideous diseases by opening a pathway into human DNA, which is exactly what this gene-therapy drug is intended to do:
The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified.
Two GGΨA sequences were found. Potential G Quadruplex sequences are possibly present but a more sophisticated computer program is needed to verify these. Furthermore, the spike protein, created by the translation of the vaccine RNA, binds angiotensin converting enzyme 2 (ACE2), a zinc containing enzyme.
More about that issue with zinc:
This interaction has the potential to increase intracellular zinc. Zinc ions have been shown to cause the transformation of TDP-43 to its pathologic prion configuration. The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer’s disease and other neurological degenerative diseases.
Dr. Classen’s ALARMING conclusion:
The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit.
Click HERE if you want to read the full report of J. Bart Classen, MD.